↓ Skip to main content

The Neuropharmacology of Alcohol

Overview of attention for book
Cover of 'The Neuropharmacology of Alcohol'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 76 Presynaptic Ethanol Actions: Potential Roles in Ethanol Seeking
  3. Altmetric Badge
    Chapter 77 Ethanol and Cytokines in the Central Nervous System
  4. Altmetric Badge
    Chapter 78 Voltage-Sensitive Potassium Channels of the BK Type and Their Coding Genes Are Alcohol Targets in Neurons
  5. Altmetric Badge
    Chapter 79 Advances in Pharmacotherapy Development: Human Clinical Studies
  6. Altmetric Badge
    Chapter 80 GABA A Receptor Subtype Mechanisms and the Abuse-Related Effects of Ethanol: Genetic and Pharmacological Evidence
  7. Altmetric Badge
    Chapter 82 Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol
  8. Altmetric Badge
    Chapter 85 Advancing Pharmacotherapy Development from Preclinical Animal Studies
  9. Altmetric Badge
    Chapter 86 Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking
  10. Altmetric Badge
    Chapter 88 Hepatic Immune System: Adaptations to Alcohol
  11. Altmetric Badge
    Chapter 89 Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
  12. Altmetric Badge
    Chapter 90 Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior
  13. Altmetric Badge
    Chapter 92 Innate Immune Signaling and Alcohol Use Disorders
  14. Altmetric Badge
    Chapter 93 Voltage-Sensitive Calcium Channels in the Brain: Relevance to Alcohol Intoxication and Withdrawal
  15. Altmetric Badge
    Chapter 98 GABA and Glutamate Synaptic Coadaptations to Chronic Ethanol in the Striatum
  16. Altmetric Badge
    Chapter 100 Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol
  17. Altmetric Badge
    Chapter 101 Transcriptional Regulators as Targets for Alcohol Pharmacotherapies
  18. Altmetric Badge
    Chapter 105 Do Alcohol-Related AMPA-Type Glutamate Receptor Adaptations Promote Intake?
  19. Altmetric Badge
    Chapter 106 Cross-Species Alterations in Synaptic Dopamine Regulation After Chronic Alcohol Exposure
  20. Altmetric Badge
    Chapter 108 Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors
  21. Altmetric Badge
    Chapter 109 The Cerebellar GABA A R System as a Potential Target for Treating Alcohol Use Disorder
  22. Altmetric Badge
    Chapter 189 Correction to: Presynaptic Ethanol Actions: Potential Roles in Ethanol Seeking
  23. Altmetric Badge
    Chapter 190 Correction to: GABA A Receptor Subtype Mechanisms and the Abuse-Related Effects of Ethanol: Genetic and Pharmacological Evidence
  24. Altmetric Badge
    Chapter 191 Correction to: Advancing Pharmacotherapy Development from Preclinical Animal Studies
  25. Altmetric Badge
    Chapter 192 Correction to: Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior
  26. Altmetric Badge
    Chapter 193 Correction to: Innate Immune Signaling and Alcohol Use Disorders
  27. Altmetric Badge
    Chapter 194 Correction to: Transcriptional Regulators as Targets for Alcohol Pharmacotherapies
Attention for Chapter 101: Transcriptional Regulators as Targets for Alcohol Pharmacotherapies
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
12 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Transcriptional Regulators as Targets for Alcohol Pharmacotherapies
Chapter number 101
Book title
The Neuropharmacology of Alcohol
Published in
Handbook of experimental pharmacology, January 2018
DOI 10.1007/164_2018_101
Pubmed ID
Book ISBNs
978-3-31-996522-2, 978-3-31-996523-9
Authors

Antonia M. Savarese, Amy W. Lasek

Abstract

Alcohol use disorder (AUD) is a chronic relapsing brain disease that currently afflicts over 15 million adults in the United States. Despite its prevalence, there are only three FDA-approved medications for AUD treatment, all of which show limited efficacy. Because of their ability to alter expression of a large number of genes, often with great cell-type and brain-region specificity, transcription factors and epigenetic modifiers serve as promising new targets for the development of AUD treatments aimed at the neural circuitry that underlies chronic alcohol abuse. In this chapter, we will discuss transcriptional regulators that can be targeted pharmacologically and have shown some efficacy in attenuating alcohol consumption when targeted. Specifically, the transcription factors cyclic AMP-responsive element binding protein (CREB), peroxisome proliferator-activated receptors (PPARs), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and glucocorticoid receptor (GR), as well as the epigenetic enzymes, the DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), will be discussed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 33%
Librarian 1 8%
Student > Bachelor 1 8%
Other 1 8%
Unknown 5 42%
Readers by discipline Count As %
Neuroscience 3 25%
Nursing and Health Professions 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Social Sciences 1 8%
Computer Science 1 8%
Other 0 0%
Unknown 5 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2018.
All research outputs
#14,973,306
of 23,031,582 outputs
Outputs from Handbook of experimental pharmacology
#379
of 647 outputs
Outputs of similar age
#255,798
of 442,391 outputs
Outputs of similar age from Handbook of experimental pharmacology
#11
of 23 outputs
Altmetric has tracked 23,031,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 647 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,391 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.